Cellectis Inc. (CLLS) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cellectis S.a..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.457 Good day, everyone, and welcome to today's Selective Second Quarter 2025 Earnings Conference 00:00:05.457 -- 00:00:09.882 Call. At this time, all participants are in a listen-only mode. 00:00:09.882 -- 00:00:13.366 Later, you will have the opportunity to ask questions during the question and answer 00:00:13.366 -- 00:00:17.288 session. You may register to 00:00:25.179 -- 00:00:29.714 ask a question at any time by pressing star 1 on your telephone keypad. 00:00:29.714 -- 00:00:33.258 you may withdraw yourself from the queue by pressing star two. 00:00:33.258 -- 00:00:38.204 Please note this call may be recorded and I'll be standing by should you need any assistance. 00:00:38.204 -- 00:00:42.809 It is now my pleasure to turn the conference over to Arthur Strill, Interim Chief Financial 00:00:42.809 -- 00:00:45.950 Officer. Please go ahead. 00:00:46.273 -- 00:00:51.599 Good morning and welcome everyone to Selectus' second quarter 2025 business 00:00:51.599 -- 00:00:54.922 update and financial results conference call. 00:00:54.922 -- 00:00:59.668 Joining me on the call today are Dr. André Choulika, our Chief Executive Officer, and 00:00:59.668 -- 00:01:03.693 Dr. Adrian Kilcoyne, our Chief Medical Officer. 00:01:03.693 -- 00:01:09.020 Yesterday evening, Selectus issued a 6K in press release reporting our financial statements 00:01:09.020 -- 00:01:13.025 for the six-month period ended June 30, 2025, 00:01:13.025 -- 00:01:18.052 and a business update. The report and press release are available on our website 00:01:18.052 -- 00:01:20.192 at selectus.com. 00:01:20.655 -- 00:01:25.651 As a reminder, We will make statements regarding Selectasys financial outlook, including 00:01:25.651 -- 00:01:30.795 the presentation of our Bally 01 and Nat...